| Authors: |
Jones S; Emerging Pathogen Serology Group, Vaccine Development Evaluation and Preparedness Centre, UK Health Security Agency, Wiltshire, UK. Electronic address: scott.jones@ukhsa.gov.uk., Hicks B; Emerging Pathogen Serology Group, Vaccine Development Evaluation and Preparedness Centre, UK Health Security Agency, Wiltshire, UK., Callaby H; Rare and Imported Pathogens Laboratory, UK Health Security Agency, Wiltshire, UK; Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen, UK., Bailey D; Rare and Imported Pathogens Laboratory, UK Health Security Agency, Wiltshire, UK., Gordon NC; Rare and Imported Pathogens Laboratory, UK Health Security Agency, Wiltshire, UK., Rampling T; Rare and Imported Pathogens Laboratory, UK Health Security Agency, Wiltshire, UK., Houlihan C; Rare and Imported Pathogens Laboratory, UK Health Security Agency, Wiltshire, UK., Jones R; Chelsea and Westminster Hospital NHS Foundation Trust, London, UK., Pond M; Imperial College Healthcare NHS Trust, London, UK., Mehta R; Imperial College Healthcare NHS Trust, London, UK., Wright D; Research and Development, Porton Down, UK Health Security Agency, Wiltshire, UK., Oeser C; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, Colindale, London, UK., Tonge S; Seroepidemiology Unit, UK Health Security Agency, Manchester, UK., Linley E; Seroepidemiology Unit, UK Health Security Agency, Manchester, UK., Rowe C; Emerging Pathogen Serology Group, Vaccine Development Evaluation and Preparedness Centre, UK Health Security Agency, Wiltshire, UK., Hallis B; Emerging Pathogen Serology Group, Vaccine Development Evaluation and Preparedness Centre, UK Health Security Agency, Wiltshire, UK., Otter A; Emerging Pathogen Serology Group, Vaccine Development Evaluation and Preparedness Centre, UK Health Security Agency, Wiltshire, UK. |
